Cue Biopharma (CUE) Times Interest Earned (2022 - 2023)
Cue Biopharma's Times Interest Earned came in at -88.96 for Q3 2022.
Powered by 
Analysis
Cue Biopharma (CUE) Times Interest Earned (2022 - 2023) Analysis & Trends
Over the trailing twelve months to Sep 30, 2022, Cue Biopharma reported Times Interest Earned of -130.29.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 28.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.20 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 5.68 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 12.87 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Cue Biopharma | 98.10 Mn | 18.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -39.93 |
| Jun 30, 2023 | -58.26 |
| Sep 30, 2022 | -88.96 |
| Jun 30, 2022 | -63.54 |
| Mar 31, 2022 | -569.52 |
API Access
Cue Biopharma Times Interest Earned API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=times-interest-earned&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "times-interest-earned", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=times-interest-earned&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();